| 2014 |
DDX21 widely associates with Pol I- and Pol II-transcribed genes and diverse RNA species including rRNA, snoRNAs, and 7SK RNA. In the nucleolus, DDX21 directly contacts rRNA and snoRNAs to promote rRNA transcription, processing, and modification. In the nucleoplasm, DDX21 binds 7SK RNA as a component of the 7SK snRNP complex and is recruited to Pol II gene promoters where it facilitates P-TEFb release from 7SK snRNP in a helicase-activity-dependent manner, promoting transcription elongation of ribosomal protein and snoRNA genes. |
ChIP-seq, CLIP-seq, RNA immunoprecipitation, shRNA knockdown, helicase-dead mutant analysis, luciferase reporter assays |
Nature |
High |
25470060
|
| 2017 |
The lncRNA SLERT interacts with DDX21 via a 143-nt non-snoRNA sequence. DDX21 forms ring-shaped structures (visualized by super-resolution microscopy) surrounding multiple Pol I complexes and suppresses pre-rRNA transcription. SLERT binding allosterically alters individual DDX21 molecules, loosens the DDX21 ring, and relieves DDX21-mediated suppression of Pol I transcription. |
Super-resolution imaging (STORM), RNA immunoprecipitation, CRISPR deletion, co-immunoprecipitation, in vitro binding assays |
Cell |
High |
28475895
|
| 2019 |
PARP-1 is activated by snoRNAs in the nucleolus and ADP-ribosylates DDX21. ADP-ribosylated DDX21 localizes to nucleoli and promotes rDNA transcription. Treatment with PARP inhibitors or mutation of the ADP-ribosylation sites on DDX21 reduces its nucleolar localization, rDNA transcription, ribosome biogenesis, protein translation, and cell growth. |
Co-immunoprecipitation, PARP inhibitor treatment, ADP-ribosylation site mutagenesis, RNA pol I transcription assays, xenograft models, immunofluorescence |
Molecular cell |
High |
31351877
|
| 2017 |
DDX21 efficiently unwinds R-loops in vitro and in cells; depletion of DDX21 leads to accumulation of cellular R-loops and DNA double-strand breaks. DDX21 helicase activity is regulated by acetylation: CBP acetylates DDX21 to inhibit its activity, while SIRT7 deacetylates DDX21 to augment helicase activity and overcome R-loop-mediated stalling of RNA polymerases. DDX21 also resolves estrogen-induced R-loops on estrogen-responsive genes. |
In vitro R-loop unwinding assay, DRIP-seq (S9.6 antibody), co-immunoprecipitation, SIRT7/DDX21 knockdown, γH2AX measurement, acetylation/deacetylation assays |
Genes & development |
High |
28790157
|
| 2011 |
DDX21 forms a complex with DDX1, DHX36, and the adaptor TRIF in the cytosol of myeloid dendritic cells to sense dsRNA. DDX21 binds the TIR domain of TRIF via its PRK domain. Knockdown of DDX21 blocks type I IFN and cytokine responses to poly I:C, influenza A virus, and reovirus, establishing DDX21 as a component of a cytosolic dsRNA sensor that activates the TRIF pathway. |
Poly I:C affinity purification, mass spectrometry, shRNA knockdown, domain-mapping binding assays, IFN/cytokine reporter assays |
Immunity |
High |
21703541
|
| 2014 |
DDX21 restricts influenza A virus by binding the viral polymerase subunit PB1 and inhibiting polymerase assembly, reducing viral RNA and protein synthesis. The viral NS1 protein overcomes this restriction by binding DDX21 and displacing PB1. Sequential interaction of PB1 and NS1 with DDX21 temporally regulates viral gene expression. |
Co-immunoprecipitation, shRNA knockdown, viral replication assays, NS1 mutant viruses with DDX21 knockdown rescue |
Cell host & microbe |
High |
24721576
|
| 2020 |
Crystal structures of human DDX21 were determined in three states: apo, AMPPNP+ssRNA-bound (pre-hydrolysis), and ADP-bound (post-hydrolysis), revealing an open-to-closed conformational change upon RNA binding. The RNA unwinding machinery includes a wedge helix, sensor motif V, and the DEVD box linking ATP and RNA binding pockets. DDX21 unwinds dsRNA cooperatively (Hill coefficient analysis). The NS1 protein of influenza A inhibits DDX21 ATPase and unwinding activity via small RNAs that cooperatively assemble with DDX21 and NS1. |
X-ray crystallography, in vitro ATPase assay, RNA unwinding assay, site-directed mutagenesis (D339H/E340G), Hill coefficient analysis |
Advanced science |
High |
32714761
|
| 2023 |
Glucose binds the ATP-binding domain of DDX21, alters its conformation, inhibits helicase activity, and dissociates DDX21 dimers. During differentiation-associated intracellular glucose elevation, DDX21 re-localizes from the nucleolus to the nucleoplasm, assembles into larger complexes containing RNA splicing factors, and promotes splicing of pro-differentiation genes (GRHL3, KLF4, OVOL1, RBPJ) by binding a specific SCUGSDGC motif in mRNA introns. |
Azido-glucose click chemistry, in vitro helicase assay, SAXS, immunofluorescence, enhanced CLIP-seq, splicing assays, DDX21 knockdown/rescue |
Cell |
High |
36608661
|
| 2024 |
DDX21 recruits the m6A methyltransferase METTL3 to chromatin by recognizing co-transcriptionally formed R-loops, and DDX21's helicase activity is required for METTL3-mediated m6A deposition onto nascent RNA. At transcription termination regions, this DDX21-METTL3 nexus promotes XRN2-mediated RNAPII termination. Loss of DDX21 or its enzymatic activity leads to defective termination and DNA damage. |
Co-immunoprecipitation, ChIP-seq, m6A-seq (MeRIP), DRIP-seq, helicase-dead DDX21 mutant, XRN2 cleavage assays, γH2AX measurement |
Molecular cell |
High |
38569554
|
| 2017 |
DDX21 binds RNA G-quadruplexes (rG4s) directly and unwinds them. The C-terminus of DDX21 mediates quadruplex RNA binding. DDX21 recognizes the quadruplex topology with specificity involving 2'OH of loop nucleotides. DDX21 binding suppresses expression of a protein with G4s in the 3' UTR of its mRNA. |
Mass spectrometry pull-down from cell lysate, fluorescence binding assays, nuclease sensitivity assay, domain truncation mapping, mRNA reporter assay |
Nucleic acids research |
Medium |
28472472
|
| 2018 |
The C-terminus of DDX21 directly binds TERRA (telomeric repeat-containing RNA) G-quadruplex. 2D saturation transfer difference NMR maps the binding site to the phosphoribose backbone of quadruplexes; specificity for TERRA is mediated by 2'OH of loop nucleotides. |
In vitro binding assays, 2D saturation transfer difference NMR, site-directed mutagenesis of 2'OH |
Biochimica et biophysica acta. General subjects |
Medium |
29906500
|
| 2020 |
DDX21 is dimeric, with a central dimerization domain identified by SAXS. Intact dimerization is essential for both ATP-dependent dsRNA unwinding and ATP-independent G-quadruplex remodeling activities in vitro. The Arg/Gly-rich C-terminus maintains high RNA affinity independent of dimerization. |
SAXS, in vitro helicase assays with dimerization-deficient mutants, G-quadruplex remodeling assays |
iScience |
Medium |
33313488
|
| 2014 |
DDX21 is required for the association of late-acting snoRNPs (SNORD56, SNORD68) with pre-40S ribosomal complexes. DDX21 crosslinking sites on pre-rRNAs overlap with basepairing sites of these late snoRNAs. Earlier snoRNAs are unaffected by DDX21 depletion, establishing DDX21 as a regulator of the ordered hierarchy of snoRNP action in pre-40S maturation. |
CRAC (crosslinking and analysis of cDNAs), sucrose gradient sedimentation, shRNA knockdown, northern blotting |
Nucleic acids research |
High |
25477391
|
| 2008 |
c-Jun directly interacts with DDX21 and regulates its nucleolar localization. Depletion of c-Jun causes translocation of DDX21 from nucleolus to nucleoplasm, reduces DDX21 binding to rRNA, and inhibits 28S and 18S rRNA accumulation. Exogenous c-Jun rescues DDX21 nucleolar localization. |
siRNA knockdown, co-immunoprecipitation, RNA immunoprecipitation, indirect immunofluorescence, northern blotting |
The Journal of biological chemistry |
Medium |
18180292
|
| 1997 |
DDX21 (RH-II/Gu) is normally a nucleolar protein and undergoes reversible translocation from nucleolus to nucleoplasm upon treatment with cytotoxic drugs (actinomycin D, toyocamycin, mycophenolic acid), with the kinetics of reversibility depending on drug dose and type. |
Immunofluorescence, drug treatment and washout experiments in MCF-7 cells |
Experimental cell research |
Medium |
9299166
|
| 2014 |
During dengue virus infection, DDX21 translocates from nucleus to cytoplasm to activate innate immune responses, thereby inhibiting DENV replication in early infection. DENV NS2B-NS3 protease complex subsequently degrades DDX21 to subvert innate immunity and facilitate replication. |
iTRAQ proteomics, LC-MS/MS, immunofluorescence, viral replication assays, protease inhibitor experiments |
Biochemical and biophysical research communications |
Medium |
27033607
|
| 2021 |
Caspase-3 and caspase-6 cleave DDX21 at D126 upon virus infection or RNA/DNA ligand treatment. The resulting cytoplasmic cleaved DDX21 fragment negatively regulates IFN-β signaling by suppressing the formation of the DDX1-DDX21-DHX36 dsRNA-sensing complex. |
Co-immunoprecipitation, site-directed mutagenesis (D126 cleavage site), caspase inhibitor treatment, IFN-β reporter assay, immunofluorescence |
mBio |
Medium |
34125604
|
| 2014 |
DDX21 promotes rRNA processing in breast cancer cells and is required for phosphorylation of c-Jun on Ser73, thereby promoting AP-1 transcriptional activity. In nuclear (non-nucleolar) localized DDX21, these two functions operate independently. |
siRNA knockdown, immunofluorescence, rRNA processing assay (northern blot/pulse-chase), luciferase reporter for AP-1 activity, qRT-PCR, xenograft imaging |
Breast cancer research : BCR |
Medium |
25260534
|
| 2017 |
In HIV-1 context: DDX21 binds the Rev Response Element (RRE) with high affinity, stimulating ATPase activity. DDX21 is both an ATP-dependent and ATP-independent helicase. Rev inhibits DDX21 ATPase and ATP-dependent helicase activities dose-dependently via a conserved DEAD-domain interaction involving Rev's nuclear diffusion inhibitory signal motif. DDX21 enhances Rev binding to the RRE. |
In vitro RNA binding assays, ATPase assay, helicase assay, pulldown, fluorescence anisotropy |
Journal of molecular biology |
Medium |
28705764
|
| 1999 |
Recombinant DDX21 (RH-II/Gu) expressed in a baculovirus system has RNA helicase activity on a 5'-tailed dsRNA substrate in vitro. Adriamycin inhibits DDX21 helicase activity (IC50 ~40 µM) by binding to the RNA substrate rather than directly to the protein. |
Baculovirus expression, in vitro helicase assay, RNA-drug binding assay (gel electrophoresis) |
Biochemical and biophysical research communications |
Medium |
10600508
|
| 2013 |
WDR46 (nucleolar scaffold protein) is required for proper localization of DDX21 to the granular component of the nucleolus. Upon WDR46 knockdown, DDX21 mislocalizes to the edges of nucleoli, and proper DDX21 recruitment after cell division is impaired. WDR46 physically interacts with DDX21 via its intrinsically disordered N- and C-terminal regions. |
siRNA knockdown, immunofluorescence, co-immunoprecipitation, cell-cycle analysis |
Genes to cells |
Medium |
23848194
|
| 2012 |
DDX21 (Gu/Ddx21) is a novel direct interactor of protein phosphatase PP1, identified by mitotic spindle enrichment and mass spectrometry. DDX21 is placed within the toposome (Topoisomerase IIα-containing complex) involved in mitotic chromatin regulation. |
Mitotic spindle biochemical enrichment, mass spectrometry, co-immunoprecipitation, in vitro binding assay |
PloS one |
Medium |
22761809
|
| 2019 |
At the ENPP2 locus, JMJD3 interacts with DDX21 (identified by mass spectrometry) and recruits DDX21 to the transcription start site and gene body. DDX21 resolves R-loops formed co-transcriptionally at ENPP2, enabling productive transcription. This JMJD3-DDX21 recruitment is controlled by a distant-acting enhancer. |
Mass spectrometry, co-immunoprecipitation, ChIP-qPCR, DRIP-qPCR (S9.6 antibody), CRISPR-Cas9 enhancer deletion |
Nucleic acids research |
Medium |
31251802
|
| 2024 |
NAT10 acetyltransferase acetylates DDX21 at K236 and K573, enhancing DDX21 helicase activity to resolve nucleolar R-loops. Acetylation-mimicking DDX21 (2KQ) has increased helicase activity, and acetylation-deficient DDX21 (2KR) has decreased activity in vitro and in cells. NAT10 loss causes nucleolar R-loop accumulation and DNA damage, rescued by co-expression of acetylation-mimicking DDX21. |
Co-immunoprecipitation, GST pull-down, mass spectrometry for acetylation sites, in vitro helicase assay, immunofluorescence with RNase H control, CRISPR/shRNA knockdown, γH2AX measurement |
Cell communication and signaling |
High |
39394182
|
| 2022 |
NAT10 and DDX21 interact with RNase H1 (via BioID proximity labeling confirmed biochemically). Purified NAT10 and DDX21 proteins enhance RNase H1 cleavage rates in vitro. Reduction of either protein decreases PS-ASO activity and increases R-loop levels and impairs pre-rRNA processing. |
BioID proximity labeling, co-immunoprecipitation, in vitro RNase H1 cleavage assay, DRIP, knockdown, northern blotting |
Nucleic acid therapeutics |
Medium |
35852833
|
| 2021 |
In zebrafish, Ddx21 cell-autonomously regulates lymphatic vessel development by supporting Vegfc-Flt4-driven endothelial cell proliferation. Loss of Ddx21 reduces ribosome biogenesis, upregulates p53 and p21, and causes cell cycle arrest that blocks lymphangiogenesis. |
Zebrafish genetic screen, morpholino/mutant analysis, cell-autonomous transplantation experiments, immunofluorescence, ribosome biogenesis assays |
Nature cell biology |
Medium |
34750583
|
| 2020 |
The phosphatase PRL3 binds DDX21 and restricts productive transcription elongation by RNAPII at MITF-regulated endolysosomal vesicle genes, controlling melanocyte stem cell differentiation. PRL3-DDX21 interaction limits transcriptional elongation as a differentiation checkpoint mechanism. |
Co-immunoprecipitation, ChIP-seq, RNAPII elongation assays, zebrafish genetic analysis, patient melanoma data |
Developmental cell |
Medium |
32652076
|
| 2020 |
Nucleotide depletion (via DHODH inhibition with leflunomide) reduces DDX21 chromatin occupancy in melanoma cells. Progesterone receptor (Pgr) binds the RNA helicase Ddx21 (proteomics). DDX21 acts as a sensor and mediator of transcription during nucleotide stress, and ddx21-deficient zebrafish show resistance to leflunomide-induced neural crest defects. |
In vivo chemical suppressor screen (zebrafish), proteomics (Pgr-DDX21 interaction), ChIP-seq, nucleotide supplementation rescue |
Nature cell biology |
Medium |
32231306
|
| 2018 |
DDX21 suppresses Snail transcription independently of its helicase activity by recruiting PRC2 subunits SUZ12 and EZH2 to the Snail promoter, establishing a double-negative feedback loop where Snail also represses DDX21 transcription. |
ChIP assay, co-immunoprecipitation, overexpression/knockdown, luciferase reporter, in vivo metastasis assay |
Cancer letters |
Medium |
30165191
|
| 2019 |
DDX21 regulates protein expression of MAGED2 through an rG4 structure in the MAGED2 5'-UTR. Cells expressing rG4-binding-deficient DDX21 (M4 mutant) show halved MAGED2 protein (but not mRNA) levels, leading to elevated TRAIL-R2 and TRAIL-mediated apoptosis sensitivity. |
Label-free proteomics, western blotting, qRT-PCR, rG4-binding-deficient DDX21 mutant expression, TRAIL apoptosis assay |
RNA |
Medium |
31653714
|
| 2022 |
DDX21 interacts with WDR5 and recruits it to the CDK1 gene promoter, enhancing H3K4me3 trimethylation to activate CDK1 transcription in colorectal cancer cells. DDX21 knockdown reduces CDK1 expression and causes G2/M phase arrest. |
Co-immunoprecipitation, ChIP assay, gene expression profiling, knockdown experiments, cell cycle analysis |
Journal of Cancer |
Medium |
35371306
|
| 2022 |
In the context of nuclear RNA activation (RNAa), CDK9 and DDX21 form a complex with nuclear AGO and TNRC6A. DDX21 inhibition suppresses RNAa by miR-34a and other miRNAs without inhibiting post-transcriptional regulation, placing DDX21 as necessary for release of paused RNAPII during RNAa. |
Co-immunoprecipitation, siRNA knockdown, Pol II ChIP, reporter assay distinguishing transcriptional vs. post-transcriptional regulation |
Cell reports |
Medium |
35417682
|
| 2021 |
DDX21 interacts with AGO2 in the nucleus in an RNA-dependent indirect manner. DDX21 upregulates AGO2 protein levels and participates in AGO2-dependent alternative splicing of SMN2. |
Co-immunoprecipitation, GST pulldown, immunofluorescence, splicing assays |
Bioscience, biotechnology, and biochemistry |
Low |
33604619
|
| 2024 |
DDX21 interacts with TERT to regulate rRNA transcription by affecting the binding of RNA Pol I to rDNA. BRAF mutation upregulates DDX21 expression through the MEK/ERK/GABP transcription factor axis (GABPA binds the DDX21 promoter). DDX21 knockdown suppresses multiple cancer hallmark gene expressions. |
Co-immunoprecipitation, mass spectrometry, ChIP-seq, Ribo-seq, RNA-seq, luciferase reporter assay, MAPK inhibitor treatment |
Thyroid |
Medium |
41817108
|
| 2024 |
Calmodulin (CaM) interacts with nucleolar DDX21 in a Ca2+-dependent manner. CaM alters DDX21 conformation to liberate DDX21-sequestered RPA194 (the catalytic subunit of RNA Pol I), facilitating rDNA transcription. This CaM-DDX21 interaction couples activity-induced Ca2+ influx to nucleolar rRNA biogenesis in hippocampal neurons. |
Co-immunoprecipitation, fluorescence binding assay, Ca2+ chelation, conformation assay, small molecule screening, axon growth assay |
The Journal of neuroscience |
Medium |
39060175
|
| 2024 |
U3 snoRNA is the predominant DDX21-binding partner during mitosis; DDX21 colocalizes with U3 snoRNA in the perichromosomal region (PR). U3 snoRNA regulates DDX21 PR localization by maintaining its mobility; DDX21 knockdown causes mitotic catastrophe similar to U3 snoRNA depletion. In vitro, Cy5-U3 snoRNA downsizes fibrous DDX21 condensates at proper molecular ratios. |
RIP, immunofluorescence, FRAP, DDX21 knockdown, U3 snoRNA depletion, in vitro condensate assay |
Cell death & disease |
Medium |
38760378
|
| 2023 |
DDX21 undergoes phase separation in vitro and in CRC cells via its intrinsically disordered region (IDR). Phase-separated DDX21 binds the MCM5 gene locus; IDR mutations disrupting phase separation reduce MCM5 binding. MCM5 overexpression rescues the impaired metastatic ability of DDX21-depleted cells, placing MCM5 as a downstream target. |
In vitro phase separation assay, IDR mutagenesis, ChIP, knockdown/rescue experiments, in vivo metastasis model |
Oncogene |
Medium |
37029300
|
| 2023 |
LINC00240 lncRNA stabilizes DDX21 protein by recruiting the deubiquitinase USP10, which removes ubiquitin from DDX21 and prevents its proteasomal degradation. |
Co-immunoprecipitation, ubiquitination assay, USP10 overexpression/knockdown, western blotting |
Journal of experimental & clinical cancer research |
Medium |
37072811
|
| 2024 |
TRIP13 (AAA+ ATPase) directly interacts with DDX21 and stabilizes it by restraining its ubiquitination degradation, promoting gastric cancer progression. |
Co-immunoprecipitation, ubiquitination assay, knockdown experiments, in vivo tumor model |
Cell death & disease |
Low |
39187490
|
| 2025 |
DDX21 competitively binds SIRT7, relieving SIRT7-mediated inhibition of NAT10, thereby upregulating NAT10 expression and enhancing NAT10-mediated ac4C modification of ATAD2, SOX4, and SNX5 mRNAs in colorectal cancer. |
Co-immunoprecipitation, western blotting, MeRIP for ac4C, knockdown/overexpression, in vivo metastasis model |
Cell death & disease |
Low |
40301349
|
| 2025 |
The small molecule KI-DX-014 (identified by small-molecule microarray against DDX21) inhibits DDX21-RNA interactions, reduces ATPase activity, modulates biomolecular condensate formation, and attenuates DDX21-dependent P-TEFb release from 7SK snRNP in vitro, suppressing RNAPII CTD phosphorylation. |
Small-molecule microarray, ATPase assay, condensate formation assay, in vitro 7SK snRNP P-TEFb release assay, zebrafish developmental assay |
ACS chemical biology |
Medium |
40637641
|
| 2021 |
DDX21 inhibits FMDV IRES-dependent translation by binding FMDV IRES domains 2, 3, and 4. FMDV counteracts this by degrading DDX21 via its non-structural proteins 2B and 2C (through the caspase pathway) and 3Cpro (through the lysosomal pathway). |
Pulldown assay, dual-luciferase assay (IRES activity), knockdown/overexpression, confocal microscopy, pathway inhibitor experiments |
Viruses |
Medium |
34578346
|
| 2025 |
HTLV-1 Gag interacts with DDX21 through zinc fingers in the NC domain, independently of RNA. DDX21 is packaged into virions. DDX21 alone enhances tRNAPro primer annealing to the HTLV-1 primer binding site, and DDX21 + RPL7 + Gag combination shows synergistic annealing activity. |
Affinity purification–mass spectrometry, reciprocal co-immunoprecipitation, domain-mapping, in vitro primer-annealing assays |
bioRxiv (preprint)preprint |
Medium |
40791341
|
| 2025 |
Ddx21 interacts with the histone demethylase Kdm5a and co-occupies H3K4me3-marked active promoters. Loss of Ddx21 reduces H3K4me3 at rDNA and hematopoietic genes (cKit, Gata1). Kdm5a inhibition restores rRNA expression and translation in Ddx21-deficient fetal hematopoietic cells, demonstrating that Ddx21 sequesters Kdm5a to maintain active chromatin for ribosomal transcription. |
Conditional knockout, multi-omics (ChIP-seq, RNA-seq, ribosome profiling), co-immunoprecipitation, Kdm5a inhibitor rescue |
bioRxiv (preprint)preprint |
Medium |
bio_10.1101_2025.09.04.674186
|